Dr. Eileen O’Reilly, MD is a Oncology Specialist in New York, NY and has over 30 years of experience in the medical field. Dr. O’Reilly has more experience with Pancreatic Oncology, Gastrointestinal Oncology, and Pulmonary Oncology than other specialists in her area.

Dr. Obeid is an Assistant Professor in the Department of Clinical Genetics and Director of Breast, Ovary, and Prostate Cancer Risk Assessment Programs, as well as the Interim Chief of Breast Medical Oncology at Fox Chase Cancer Center. He attended medical school at the American University of Beirut School of Medicine, in Beirut, Lebanon and received a Master’s of Public Health degree from the University of Massachusetts. He completed his fellowship training in Medical Oncology and Hematology at the University of Chicago. Dr. Obeid focuses on the treatment of breast cancer, with particular interest in the treatment of triple-negative and hereditary breast cancers, as well as Breast, Ovary, and Prostate cancer risk assessment.

Dr Joanne Ngeow, MBBS, MRCP, MPH is Senior Consultant, Division of Medical Oncology at the National Cancer Centre Singapore and Associate Professor, Lee Kong Chian School of Medicine, Nanyang Technological University. Dr Ngeow currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic interest in hereditary cancer syndromes and translational clinical cancer genetics. She was awarded consecutive fellowships by the National Medical Research Council and the Ambrose Monell Foundation to complete formal clinical and bench training in Cancer Genomic Medicine at the Genomic Medicine Institute, Cleveland Clinic, Ohio. Dr Ngeow’s research focuses on understanding how a gene-environmental interaction predisposes to cancer initiation and progression. Her team seeks to identify, characterize and understand genes which cause susceptibility to traditional and complex heritable cancer syndromes, to determine their role in sporadic carcinogenesis. The Cancer Genetics Service led by Dr Ngeow is the go-to for clinical cancer genetics in Singapore and the region. Dr Ngeow is funded by the National Medical Research Council, Terry Fox Foundation and Lee Foundation. Her work is published in over 70 peer-reviewed top scientific journals and she is the recipient of consecutive scientific awards from the American Society of Clinical Oncology and Endocrine Society in recognition of her contributions to the field of cancer genomic medicine.

Dr. John Chia is a medical oncologist practicing at Mount Elizabeth Novena Hospital, Singapore. His subspeciality interests include ovarian, endometrial, cervical, breast and colorectal cancers, as well as the management of rare tumours such as melanoma, uterine sarcoma, and germ cell tumours. He sits on the scientific board of the International Aspirin Foundation, and lectures widely, in Japan, Korea, HK, China and UK, as well as plenary symposia lectures in Germany, Australia and ESMO Asia. He is also a consultant at several biotechnology and pharmaceutical companies, advising the development of novel therapeutics and immunotherapy for cancer. Dr Chia sits on the Singapore Cancer Society’s Women’s Gynaecological Cancer Awareness Committee, and has helped to write the Singapore ovarian and uterine cancer management guidelines (SCAN). He also sits on the executive committee of the Singapore Society of Oncology (SSO) and their Cancer Immunotherapy Consortium, aiming to promote access, recruitment, and immune monitoring and toxicity management for patients on immunotherapeutic treatments in Singapore.

Omal Khair is currently a Consultant in the Division of Adult Medical, Department of Oncology in Ministry of National Guard Health Affairs – Saudi Arabia and Assistant Professor at the King Saud bin Abdulaziz University for Health Sciences.

Mediclinic City Hospital Dr. Shaheenah Dawood's specialty is Oncology and currently works as a Consultant Oncologist in Mediclinic City Hospital. She currently serves as president of the Excellence in Oncology Care (EIOC) congress that is held annually in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS) & APGCS.

Dr. Shaheenah Dawood is a Consultant medical oncologist and associate professor in clinical oncology in the United Arab Emirates. She trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training she was awarded multiple scholar in training awards and ASCO merit awards. She has served as an editorial fellow at the New England Journal of medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles and 12 book chapters. She serves as a reviewer for multiple journals including the Journal of Clinical Oncology. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the excellence In Oncology Care Congress that is held annually in Dubai and is co-president of the Asia pacific breast cancer summit (ABCS) and Asia pacific gastrointestinal cancer summit (APGCS). She has also recently launched the international BRCA forum and MENA immune-oncology summit.

One of Pune’s best breast cancer specialists and medical oncologist, Dr Shona Nag is known for her work in women’s health – especially breast cancer and cervical cancer. With over 27 years of practise, Dr Shona Nag, who studied medicine in Pune’s BJ Medical College, followed by an oncology fellowship at Tata Memorial Hospital in Mumbai, has made it her mission to encourage everyone to understand cancer better, particularly women.Currently the director, oncology at Sahayadri Group of Hospitals in Pune, Dr Shona Nag has been instrumental in helping patients navigate cancer better by also looking at pushing for new facilities and better care.

Dr Tira Tan’s research interest is in the study of breast cancer and geriatric oncology. In particular, her focus is on triple negative breast cancer and the conduct of early phase clinical trials. Her academic training and clinical experience has provided her with a broad and solid foundation in medical oncology.